Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 monoclonal antibody
The Journal of Allergy and Clinical Immunology | Jun 16, 2018
Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials
Journal of the European Academy of Dermatology and Venereology | Jun 14, 2018
Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: Results from the randomized VOYAGE 1 trial
Journal of the European Academy of Dermatology and Venereology | Jun 13, 2018